Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life

被引:77
|
作者
Hundley, JL
Carroll, CL
Lang, W
Snively, B
Yosipovitch, G
Feldman, SR
Jorizzo, JL
机构
[1] Wake Forest Univ, Sch Med, Dept Dermatol, Ctr Dermatol Res, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA
关键词
D O I
10.1016/j.jaad.2004.12.015
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Dermatomyositis affects visible skin and causes disease symptoms that can affect patients' quality of life (QOL). Methods: In all, 71 patients with dermatomyositis or dermatomyositis sine myositis completed two QOL measures (the Skindex-16 and the Dermatology Life Quality index) and a visual analog scale for pruritus. Disease severity was assessed by Physician's Global Assessment. Results: The mean Dermatology Life Quality Index score was 10.7 and the mean Skindex-16 score was 51.1. Itching contributed to impact on both the Dermatology Life Quality Index and Skindex-16. Females reported worse QOL. Limitations: The effect of treatment on quality of life was not assessed in these analyses. Conclusion: QOL impairment in dermatomyositis is greater than in other skin conditions including psoriasis and atopic dermatitis. Pruritus is an important treatable factor that significantly impacts QOL for patients with dermatomyositis.
引用
收藏
页码:217 / 220
页数:4
相关论文
共 50 条
  • [41] Quality of Life in Lupus and Dermatomyositis
    Verma, S. M.
    Werth, V. P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (05) : 1485 - 1485
  • [42] Evaluating quality of life in dermatomyositis
    Goreshi, R.
    Chock, M.
    Fiorentino, D.
    Feng, R.
    Foering, K.
    Okawa, J.
    Rose, M.
    Werth, V. P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S54 - S54
  • [43] Quality of life is significantly impaired in nonallergic rhinitis patients
    Segboer, C. L.
    Terreehorst, I.
    Gevorgyan, A.
    Hellings, P. W.
    van Drunen, C. M.
    Fokkens, W. J.
    ALLERGY, 2018, 73 (05) : 1094 - 1100
  • [44] Quality of life (QoL) is significantly impaired in patients with pemphigus
    Saha, M.
    Grieve, S.
    Groves, R. W.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 : 50 - 50
  • [45] The impact of motor and depressive symptoms on quality of life in patients with Parkinson's disease
    Jiang, Jiin-Ling
    Tsai, Sheng-Tzung
    Hsieh, Tsung-Cheng
    Lee, Chi-Wei
    Lin, Sheng-Huang
    Chen, Shin-Yuan
    TZU CHI MEDICAL JOURNAL, 2013, 25 (03): : 175 - 178
  • [46] Impact of improvement of sleep disturbance on symptoms and quality of life in patients with functional dyspepsia
    Nakamura, Fumihiko
    Kuribayashi, Shiko
    Tanaka, Fumio
    Kawami, Noriyuki
    Fujiwara, Yasuhiro
    Iwakiri, Katsuhiko
    Kusano, Motoyasu
    Uraoka, Toshio
    BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [47] Depressive symptoms and disability in chagasic stroke patients: Impact on functionality and quality of life
    de Souza, Aline Cristina
    da Costa Rocha, Manoel Otavio
    Teixeira, Antonio Lucio
    Dias Junior, Jose Olimpio
    Pereira de Sousa, Lidiane Aparecida
    Pereira Nunes, Maria Carmo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 324 (1-2) : 34 - 37
  • [48] The impact of nonmotor symptoms on quality of life in patients with Parkinson's disease in Taiwan
    Liu, Weng-Ming
    Lin, Ru-Jen
    Yu, Rwei-Ling
    Tai, Chun-Hwei
    Lin, Chin-Hsien
    Wu, Ruey-Meei
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 2865 - 2873
  • [49] Impact on quality of life in multiple sclerosis patients: Which urinary symptoms are to blame?
    Ziadeh, T.
    Mjaess, G.
    El Helou, J.
    Zalaket, J.
    Mouawad, C.
    Azar, C.
    Abboud, H.
    Koussa, S.
    Nemr, E.
    El Helou, E.
    PROGRES EN UROLOGIE, 2022, 32 (10): : 711 - 716
  • [50] The impact of residual symptoms on relapse and quality of life among Thai depressive patients
    Tantrarungroj, T.
    Nakawiro, D.
    Wongpakaran, T.
    Wongpakaran, N.
    Bookkamana, P.
    Pinyopornpanish, M.
    Lueboonthavatchai, P.
    Apisiridej, N.
    Saisavoey, N.
    Wannarit, K.
    Srichan, T.
    Ruktrakul, R.
    Satthapisit, S.
    Temboonkiat, A.
    Tubtimtong, N.
    Rakkhajeekul, S.
    Wongtanoi, B.
    Tanchakvaranont, S.
    Srisutasanavong, U.
    Nivataphand, R.
    Petchsuwan, D.
    EUROPEAN PSYCHIATRY, 2017, 41 : S326 - S327